CalciMedica Statistics

Total Valuation

CalciMedica has a market cap or net worth of $22.78 million. The enterprise value is $7.58 million.

Market Cap	22.78M
Enterprise Value	7.58M

Important Dates

The next estimated earnings date is Monday, May 12, 2025, after market close.

Earnings Date	May 12, 2025
Ex-Dividend Date	n/a

Share Statistics

CalciMedica has 13.48 million shares outstanding. The number of shares has increased by 150.68% in one year.

Current Share Class	13.48M
Shares Outstanding	13.48M
Shares Change (YoY)	+150.68%
Shares Change (QoQ)	+16.39%
Owned by Insiders (%)	11.56%
Owned by Institutions (%)	16.91%
Float	5.40M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.82
P/TBV Ratio	1.82
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.34

Current Ratio	5.34
Quick Ratio	5.07
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -121.42% and return on invested capital (ROIC) is -134.07%.

Return on Equity (ROE)	-121.42%
Return on Assets (ROA)	-94.61%
Return on Invested Capital (ROIC)	-134.07%
Return on Capital Employed (ROCE)	-150.24%
Revenue Per Employee	n/a
Profits Per Employee	-$978,571
Employee Count	14
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -70.56% in the last 52 weeks. The beta is 1.24, so CalciMedica's price volatility has been higher than the market average.

Beta (5Y)	1.24
52-Week Price Change	-70.56%
50-Day Moving Average	1.88
200-Day Moving Average	3.20
Relative Strength Index (RSI)	64.18
Average Volume (20 Days)	20,499

Short Selling Information

The latest short interest is 108,095, so 0.80% of the outstanding shares have been sold short.

Short Interest	108,095
Short Previous Month	110,224
Short % of Shares Out	0.80%
Short % of Float	2.00%
Short Ratio (days to cover)	1.86

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-24.20M
Pretax Income	-14.94M
Net Income	-13.70M
EBITDA	-24.15M
EBIT	-24.20M
Earnings Per Share (EPS)	-$1.22

Full Income Statement

Balance Sheet

The company has $18.67 million in cash and n/a in debt, giving a net cash position of $18.67 million or $1.38 per share.

Cash & Cash Equivalents	18.67M
Total Debt	n/a
Net Cash	18.67M
Net Cash Per Share	$1.38
Equity (Book Value)	14.41M
Book Value Per Share	1.07
Working Capital	15.98M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$21.15 million and capital expenditures -$8,000, giving a free cash flow of -$21.15 million.

Operating Cash Flow	-21.15M
Capital Expenditures	-8,000
Free Cash Flow	-21.15M
FCF Per Share	-$1.57

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CalciMedica does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-150.68%
Shareholder Yield	-150.68%
Earnings Yield	-52.19%
FCF Yield	-80.59%

Analyst Forecast

The average price target for CalciMedica is $16.33, which is 866.27% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$16.33
Price Target Difference	866.27%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1